Evidence map›Paper›PMID 37111555›Full record

ArticlePharmaceutics2023

Development and Application of a Dissolution-Transfer-Partitioning System (DTPS) for Biopharmaceutical Drug Characterization.

Christian Jede, Laura J Henze, Kirstin Meiners, Malte Bogdahn, Marcel Wedel, Valeria van Axel

Abstract read
In one paragraph

Article in Pharmaceutics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. IVIVC Revised.Pharmaceutical research · 2024
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Christian JedeGlobal Analytical Development, Global CMC Development, Merck Healthcare KGaA, Frankfurter Strasse 250, 64293 Darmstadt, Germany.ORCID 0000-0003-0965-7319
Laura J HenzeGlobal Analytical Development, Global CMC Development, Merck Healthcare KGaA, Frankfurter Strasse 250, 64293 Darmstadt, Germany.
Kirstin MeinersGlobal Analytical Development, Global CMC Development, Merck Healthcare KGaA, Frankfurter Strasse 250, 64293 Darmstadt, Germany.
Malte BogdahnGlobal Drug Product Development, Global CMC Development, Merck Healthcare KGaA, Frankfurter Strasse 250, 64293 Darmstadt, Germany.
Marcel WedelGlobal Drug Product Development, Global CMC Development, Merck Healthcare KGaA, Frankfurter Strasse 250, 64293 Darmstadt, Germany.
Valeria van AxelGlobal Analytical Development, Global CMC Development, Merck Healthcare KGaA, Frankfurter Strasse 250, 64293 Darmstadt, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A variety of in vitro dissolution and gastrointestinal transfer models have been developed aiming to predict drug supersaturation and precipitation. Further, biphasic, one-vessel in vitro systems are increasingly applied to simulate drug absorption in vitro. However, to date, there is a lack of combining the two approaches. Therefore, the first aim of this study was to develop a dissolution-transfer-partitioning system (DTPS) and, secondly, to assess its biopredictive power. In the DTPS, simulated gastric and intestinal dissolution vessels are connected via a peristaltic pump. An organic layer is added on top of the intestinal phase, serving as an absorptive compartment. The predictive power of the novel DTPS was assessed to a classical USP II transfer model using a BCS class II weak base with poor aqueous solubility, MSC-A. The classical USP II transfer model overestimated simulated intestinal drug precipitation, especially at higher doses. By applying the DTPS, a clearly improved estimation of drug supersaturation and precipitation and an accurate prediction of the in vivo dose linearity of MSC-A were observed. The DTPS provides a useful tool taking both dissolution and absorption into account. This advanced in vitro tool offers the advantage of streamlining the development process of challenging compounds.

Indexed as

gastrointestinalin vitro dissolution methodsin vitro dissolution testingin vivo dissolutionoral bioavailabilityoral drug absorption

Identifiers

PMID37111555
PMCPMC10145677

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.